- Report
- March 2024
- 195 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- September 2023
- 93 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- April 2024
- 93 Pages
Global
From €5439EUR$5,600USD£4,647GBP
- Report
- February 2024
- 170 Pages
Global
From €4759EUR$4,900USD£4,066GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,037GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Report
- March 2024
- 195 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2914EUR$3,000USD£2,489GBP
- Clinical Trials
- April 2024
- 115 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1214EUR$1,250USD£1,037GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Report
- April 2024
- 185 Pages
Global
From €4759EUR$4,900USD£4,066GBP
- Report
- March 2024
- 200 Pages
Global
From €4031EUR$4,150USD£3,443GBP
- Report
- October 2023
- 158 Pages
Global
From €2428EUR$2,500USD£2,074GBP
- Clinical Trials
- February 2024
- 294 Pages
Global
From €2428EUR$2,500USD£2,074GBP
- Report
- June 2023
- 74 Pages
Global
From €3394EUR$3,495USD£2,900GBP
- Report
- September 2023
- 280 Pages
Global
€4657EUR$4,795USD£3,979GBP
Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis.
The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more